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Abstract
Lateral phase separations in biological membranes are of great interest, making Electron Spin Resonance (ESR) spectroscopy combined with spin labelling a non destructive and sensitive technique for the study of lipid rafts. This is currently accepted that spin probe localization is on the plasma membrane. However, no study confirms this hypothesis. Herein, we report, for the first time, an accurate multi spectral method for the quantification of lipid spin label presence in every sub-cellular fraction. Cells were incubated with 5-doxyl stearic acid derivative and then sub-fractionated. Results of our multimodal spectroscopy approach ubiquitously demonstrate that the presence of ESR spin label only sets in the plasma membranes.














It is now well recognized that plasma membrane is one of the most important elements in cell metabolism. Active in many fields such as cell locomotion, exclusion of toxic ions, interaction with molecules or cells, the membrane is often the first element to be affected in many human diseases [1]. No more defined by the fluid mosaic model described by Singer and Nicholson [2], it is now accepted that cell membranes are complicated entities partitioned in different domains [3-7]. These domains are now referred to under the general heading of lipid rafts which are small (10-200 nm) heterogeneous, highly dynamic, sterol- and sphingolipid-enriched domains that compartmentalize cellular processes [8]. However, the issue related to the role and the real nature of raft must still be clarified. Their morphology, size, density and molecular composition are until now under consideration, and the scientific community is intensely debating about these microdomains [9-13]. Electron Spin resonance spectroscopy (ESR) associated with spin labelling fits particularly well in with the study of the structural and dynamic properties of cellular membranes and in particular with the changes in lipid bilayer organisation [5, 14-16]. Such studies are based on the introduction of lipophilic spin probe molecules into biomembranes. As the ESR spectrum is strongly dependent on the environment in which the nitroxide probe is placed, the analysis of its motion in terms of hyperfine splittings, g factor and line width gives information about the spin probe surroundings [17]. ESR spectra of probes embedded in cell membrane are generally composed of several superimposed spectral components due to cell membrane complexity [18].  In view of the evidence for lateral phase separations in biological membranes, it is generally accepted that each component of the spectrum refers to a selected area in the membrane.  Previously, our team demonstrated that the flexibility of certain probes must also be taken into consideration in the ESR spectrum analysis [19]. Another point widely accepted is that spin probes are only localized in the plasma membrane and thus that the probes’ ESR spectrum provides information just about the latter [17, 20]. To the best of our knowledge, no study confirms this hypothesis. Therefore, this work proposes to examine the positioning of one typical ESR spin label in cells and the possibility that the probes are trapped in other places than in the plasma membrane. To be the more accurate as possible, the ESR results were compared to mass spectrometric investigations and fluorescence imaging.

2. Material and methods
2.1 Cell culture
The human colon carcinoma cell line HCT-116 was cultured in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Belgium) supplemented with 10% foetal calf serum (Invitrogen, Belgium), 2 mM of L-glutamine, penicillin (100 U/ml), streptomycin (100 mg) (Invitrogen, Belgium) and was maintained in a humidified 37 °C, 5% CO2 incubator. Cells were not used at passages higher than 20. 

2.2 Sample preparation 
The non denaturising sub-fractionation method of the cells is based on the method of Gorski [21] and Mazzucchelli [22]. Briefly, cells from two T175 flasks 90% confluent were collected after trypsinization, centrifuged during 7 minutes (240 g), and the pellet was suspended in 1 mL of phosphate buffer saline solution (PBS, pH 7.4). Stearic acid derivative labelled by stable doxyl radical ring at the C-5 (5-DSA)(Aldrich, USA) was then added to achieve 10-4 M concentration and incubated during one minute. The solution was then centrifuged 5 minutes at 400 g. 10 mL of buffer A (Hepes-KOH 10 mM, pH 7.6; KCl 10 mM; Spermine/HCl 0.15 mM; Spermidine 0.5 mM; DTT 0.5 mM) was added to the cell pellet. After 10 minutes incubation in ice, the cell suspension was centrifuged at 800 g during 5 minutes and cells were recovered. One volume equivalent to the fresh weight of buffer A was then added and the solution was homogenized with 10 strokes with a motorized potter Elvehjem homogenizer (Teflon/glass) at 4000 rpm. The disruption of the cell membrane was controlled with an inverted phase contrast microscope (Nikon diaphot). 
To restore the isotonicity of the solution, 10 % in volume of buffer B (Hepes-KOH 10 mM, pH 7.6; KCl 1 M; Spermine/HCl 0.15 mM; Spermidine 0.5 mM; DTT 0.5 mM) was added. The solution was homogenized with 10 strokes at 4000 rpm and centrifuged 10 minutes at 1100 g. The supernatant and the pellet were both recovered in two different tubes respectively tubes 1 and 2. 
The tube 1 (containing the supernatant) was centrifuged during one hour at 24 x103g in order to separate the organelles and the cytosol. The plasma and the Golgi membranes, the mitochondria, lysosomes and peroxisomes that sediment between 7.5x103 and 2x105 gxmin [23], were gathered in the pellet. It was named as membrane fraction due to the preponderance of the plasma membrane in this fraction. The supernatant corresponds to the cytosolic fraction which contains the cytosol and the endoplasmic reticulum (rough and smooth) which mainly sediments over 5x105. Each sample was analysed by ESR and mass spectroscopy. Previously, the pellet containing the membrane fraction was suspended in 1 mL of pure ethanol and sonicated. 
The tube 2 (containing the nuclei) was suspended and homogenized in buffer C (Hepes-KOH 10 mM, pH 7.6; KCl 100 mM; Spermine/HCl 0.15 mM; Spermidine 0.5 mM; DTT 0.5 mM) with 5 strockes at 800 rpm. To clean the nuclei (elimination of plasma membranes fractions) the solution was centrifuged at 1100g (under the organelles sedimentation speed) during 5 minutes and the step was repeated three times. The nuclei were then homogenized in 1 mL of ethanol, sonicated and passed through ESR and mass spectrometry. Previously, the purity of the nuclei was controlled with an inverted phase contrast microscope. 

2.3 Measurement of cellular 5-DOXYL-stearic acid levels by Liquid chromatography (LC) tandem mass spectrometry
Mass spectrometry (MS) detection was carried out using an Ultima triple quadrupole instrument (Waters, UK) operating under MassLynx 3.5 and configured with a Z-spray electrospray ionization source. Infusion of 5-DSA (10-5 M in ethanol/water 75/25 containing 0.1% ammoniac) in the MS source at 10 ul/min allowed the optimisation of the following parameters: negative ion mode, capillary voltage (-2.6 kV), cone voltage (-48 V), source temperature (100°C), desolvation temperature (300°C), cone gas flow (nitrogen 87 L/h) and desolvation gas flow (nitrogen 488 L/h). The MS-MS fragmentation of the molecular ion was achieved with collision energy of 25 eV (collision gas: argon). 
LC-MS/MS was undertaken to quantify 5-DSA in the subcellular fractions. The LC model coupled to the MS system possessed a quaternary pump, a vacuum degasser, an autosampler and a thermostated column compartment (HP 1100 series, Agilent Technologies, Waldbronn, Germany). A C18 column (Nucleosil AB column (5 um, 70 x 2 mm I.D.) from Macherey–Nagel (Düren, Germany) was used and 5-DSA was diluted using a solvent gradient made of a mixture of water, acetonitrile and ammoniac.

2.4 Measurement of cellular 5-DOXYL-stearic acid levels by ESR
All ESR experiments were performed at 9.5 GHz using a Bruker ESR 300E spectrometer (Bruker, Germany) equipped with a variable temperature controller accessory and operating at a center field strength of 3480 G with 100 G as sweep width, a modulation amplitude of 2.55 G and 20.2 mW microwave power. The time constant and the conversion time were respectively 40.28 and 20.48 ms and the results are the average of three different scans. 
The double integral over the all ESR spectrum is correlated to the number of unpaired electrons inside the sample, and so, in our case to the 5-DSA concentration. Consequently, a curve of the calculated ESR signal double integral intensity in function of well known 5-DSA concentrations was made and used as standard curve. In practice, spectra of increasing concentrations of 5-DSA solubilized in ethanol mixture (0-10-4 M) were done. A linear increase was found (data not shown) in accordance with literature for 5-DSA smaller than 10-4M [24-26]. This curve allows us to quantify the label concentration in the different subcellular fractions. 
The addition of the calculated probe concentrations found inside the three sub-cellular fractions was equal to 8.2 ± 1.9 10-5 M, meaning that there was no significant loss of probe during the subcellular protocol used above.
2.5  Measurement of 5-DOXYL-stearic acid in cells by ESR
As described previously, cells from two T175 flasks 90% confluent (15 X 106) were collected after trypsinization, centrifuged during 7 minutes (240 g), and the pellet was suspended in 1 mL of phosphate PBS. 5-DSA was then added to achieve 10-4 M concentration and incubated during one minute. The solution was transferred into the quartz cell (500 µl) for ESR measurements. The spectra were obtained in the same condition as described in 2.4 except for the time constant and the conversion time which were respectively equal to 2.56 and 163.84 ms.  

2.6 Fluorescence microscopy experiments
For fluorescence microscopy experiments, cells from six T175 flasks 90% confluent were collected in medium after trypsinization and divided in three parts. Each part was labelled with one specific fluorescent probe as described in the manufacturer instructions. Fluorescent probes were Mitotracker Green Mitochondrion-Selective Probes, ER-Tracker Blue-White DPX or Hoechst (Molecular Probe, Belgium). 
The three successive controls, corresponding of each labelling on the entire cell, were replaced on the microscope. Fluorescence images were then acquired with a commercial CLSM device (Leica TCS SP5 AOBS, Mannheim, Germany) equipped with a Leica oil immersion objective (63X/1.4 NA), and producing images in direct slow scanning mode (400Hz). Fluorescent images of the different probes specifically localized were obtained under excitation with the 364-nm (Hoechst and ER-tracker) or 488 nm (Mitotracker Green) line of argon laser (the average laser power was less than 3µW at the sample). Once the subcellular localization of the fluorescent probes was confirmed by visual inspection, cells were subfractioned as described in the sample preparation. Each subcellular fraction was then replaced on the microscope and the acquisition of the images was done in the same condition as described before. The commercial Leica image-analysis (LAS AF, Leica, Germany) and ImageJ software were then used to analyse the images which were false colored coded for display. Experiments were triplicated under minimal ambient light, leading to the quantitative fluorescence calculation of at least 40 separate fragments imaging. These were then averaged.

3. Results and discussion
3.1 Mass spectrometric measurements 
The MS analysis of 5-DSA was first investigated by direct introduction of these reference compounds (10-5 M) dissolved in an ethanol/water/ammoniac (75/25/0.1 v/v/v) mixture using the electrospray interface in the negative mode of ionization. Parameters such as the capillary and cone voltages, as well as the cone and the desolvation gas flows were optimized in order to generate the highest deprotonated molecular ion under a stable spray (cf. Material and Method).Two main peaks were observed corresponding respectively to the [M - H]- (m/z= 383.5) and [M - CH2-CH2-CH2-COOH]- (m/z= 297.8) ionic species (cf. Figure 1A). 
Elsewhere, the collision - induced dissociations (CID) of 5-DSA, mainly generate the characteristic product ions of m/z 312 using a collision energy of 25 eV (cf. Figure 1B). As the multiple reaction monitoring (MRM) mode is based on the transition involving the specific molecular ion and a characteristic fragment ion, high detection selectivity as well as high signal-to-noise ratios could be obtained.
Figure 2 represents 5-DSA proportion found by LC-MS-MS in the 3 sub-cellular fractions (namely membrane, nuclei and cytosol fraction). Most of the probe was detected in the membrane fraction. But it is worth noting that 5-DSA was also found in the nuclei and cytosolic fractions (22 and 15% respectively), compared to what was detected in membrane fraction).

3.2 Electron spin resonance measurements
Figure 3A shows the typical ESR spectrum of 5-DSA incorporated in cell membranes after 1 minute of 5-DSA incubation in a phosphate buffer saline solution. This spectrum is characteristic of a probe which invested the hydrophilic cell membrane at 25°C [16].
Figure 3 B points up the typical ESR spectra of 5-DSA in the different sub-cellular fractions. The presence of probes inside the membrane and the kern fractions is clearly highlighted. However, the ESR spectra are no more corresponding to the strong anisotropic rotation observed previously but result to an isotropic probe movement. This behaviour arises because the membrane and kern fraction were treated with pure ethanol with a consequent sonication destroying all membranes in the sample (see material and method 2.2). 
The spectra intensities of Figure 3B indicate that the probe is more positioned in the membrane fraction than in the nuclei fraction. A quantitative analysis reveals that on average there are 3.5 (± 0.5) times more probes which were found in the membrane than in the nuclei fraction. Indeed a concentration of 5.9 ± 0.5 10-5 M and 1.7 ± 1.0 10-5 M were calculated respectively in the membrane fraction and in the nuclear fraction. These data are consistent with those obtained by mass spectrometry which ascertains a significant percentage of spin labels in the kern fraction. 
By contrast, the ESR spectrum of the cytosolic fraction (Figure 3B gray line and Figure 3C) doesn’t present the three peaks characteristic of free 5-DSA in solution (Figure 3D) suggesting that no probe is entrapped in the cytosolic fraction. But the mass spectrometry data clearly indicates the opposite. However, Figure 3C points up a large distorted peak. It may result in a broad anisotropic signal corresponding to slow rotation of 5-DSA. This is probably due to the incorporation of the probe in the endoplasmic reticulum (ER) and in the vesicles of the cytosol. Indeed this subcellular fraction is the only one which has not been sonicated and doesn’t contained ethanol. Consequently 5-DSA is not well solubilized and it explains the very low signal/ noise ratio observed on the figure. Such interpretation, corroborated the mass spectrometry data and supported the presence of 5-DSA in the cytosolic fraction.
Essential in the internal membrane organization of eukaryotic cells, the ER is in continuity with the outer layer of the nuclear envelope and in relationship with other compartments, including vesicles and the Golgi apparatus [27]. ER could be seen as the vehicle carrying the probes of the plasma membrane to the nucleus, explaining at the same time the significant presence of the probe both in the cytosolic fraction and in the nuclei suspension [28]. But it is important to notice that this phenomenon takes time and is highly unlikely in the case of our experiments. Another hypothesis explaining the presence of the probe in the whole sub-cellular fraction could be the 5-DSA diffusion through the plasma membrane during the extraction.

3.3 Fluorescence imaging
Previously to the fluorescence analysis of the three sub-cellular fractions, we have controlled the sub-cellular localization of the mitochondria, ER and nucleus fluorescent probes. Analysis of the images clearly indicates a good and stable localization of the different probes (Figure 4). They didn’t appear to migrate in other organelles during time (more than 6 hours), especially the ER probe. This confirms that in our time conditions of experiments, ER cannot be considered as a probe vector between the plasma membrane and the nucleus. 
Cells were then sub-fractionated (as described in the material and methods) and fluorescent signatures of mitochondria, ER and nucleus probes were purchased in each sub-cellular fraction (nuclei, membrane and cytosolic fractions respectively). Results of the fluorescent statistical analysis are represented on figure 4G, 4H and 4I. As expected, Hoechst fluorescence was only detected in the nucleus fraction (Figure 4G). The ER- tracker was widely located in the cytosolic fraction, but a significant percentage of the tracker was also found in the other sub-cellular fractions (figure 4H). This could be the result of a non specificity of the probe localization. However the fluorescence contrast between the cytosolic fraction and the other two fractions is too high (higher than two), indicating that this non specific probe localization most probably outcome from the subfractionation protocol. Similar results were obtained with the Green Mitotracker, which was found in the membrane fraction, but once again a significant part of the fluorescent probe was also found in the nucleus suspension. More precisely, there are three times more Mitotracker in the membrane fraction than in the nuclei suspension (Fig 4I). These results once again strongly suggest that the presence of ER-tracker and green Mitotracker probes in the nuclear compartment is in majority due to the sub-fractionation protocol. To support this hypothesis, the ratio of the probes in each sub-cellular fraction is similar to the one found for 5-DSA using ESR and mass spectrometry techniques.

4. Conclusion
HCT-116 cells were put in contact with a typical ESR spin probe and were then subfractionated in order to know if the probe was able to diffuse inside the cells and could be located in other sub-cellular membranes than the plasma one. ESR and MS techniques  demonstrate that the 5-DSA probe lies in majority in the membrane fraction but that was also entrapped in the cytosolic and in the nuclei fractions. However, ESR spectroscopy was significantly sensitive only to probe localized in the membrane and nuclei fraction. The purity of the subcellular fraction was investigated by fluorescence microscopy and data put in evidence that the nuclei probe localization was only due to the subfractionated method. These results are consistent with the fact that ESR is sensitive only to probe located in the membrane fraction which is in majority composed of the plasma membrane. Consequently the ESR spectra can be interpreted only from the different lateral phase separations of the plasma membrane.
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Fig. 1: (A) MS spectra of 5-DSA. (B) MS-MS spectra of 5-DSA

Fig. 2: 5-DSA proportion in the 3 sub-cellular fractions, namely membrane, nuclei and cytosol

Fig. 3: (A) Typical ESR spectrum of 5-DSA in cells before the sub-fractionation protocol; (B) Typical ESR spectra of 5-DSA in the membrane fraction (dotted line), in the cytosolic fraction (gray line) and in the nuclei (black line). (C) Same 5-DSA ESR spectrum in the cytosolic fraction as displayed in A. (D) ESR spectrum of 5-DSA (10-5 M) dissolved in PBS.

Fig. 4: (A) and (D): transmission images of HCT 116 cells. Confocal fluorescence images of ER-tracker (B) and Green Mitotracker (E) in HCT-116 cells before sub-fractionation. ER tracker (C) and Green Mitotracker (F) after 6 hours of incubation in HCT-116 cells. Mean fluorescence intensities in different sub-cellular fraction; Hoechst (G), ER-tracker (H), Green Mitotracker (I). 
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